Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 13 | 2025 | 233 | 2.920 |
Why?
|
| Transcatheter Aortic Valve Replacement | 5 | 2025 | 197 | 2.010 |
Why?
|
| Aortic Valve Stenosis | 5 | 2025 | 332 | 1.910 |
Why?
|
| Acute Coronary Syndrome | 6 | 2025 | 203 | 1.760 |
Why?
|
| ST Elevation Myocardial Infarction | 5 | 2024 | 107 | 1.760 |
Why?
|
| Coronary Stenosis | 2 | 2024 | 71 | 1.600 |
Why?
|
| Coronary Angiography | 6 | 2024 | 421 | 1.260 |
Why?
|
| Coronary Artery Bypass | 10 | 2023 | 490 | 1.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 594 | 0.930 |
Why?
|
| Coronary Vasospasm | 1 | 2024 | 10 | 0.920 |
Why?
|
| Nitroglycerin | 1 | 2024 | 23 | 0.920 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 2 | 2021 | 14 | 0.880 |
Why?
|
| Aortic Valve | 5 | 2025 | 437 | 0.870 |
Why?
|
| Vasodilator Agents | 1 | 2024 | 204 | 0.820 |
Why?
|
| Sarcoma, Synovial | 1 | 2022 | 21 | 0.810 |
Why?
|
| Thrombolytic Therapy | 2 | 2021 | 204 | 0.790 |
Why?
|
| Myocardial Infarction | 5 | 2024 | 1003 | 0.760 |
Why?
|
| Coronary Artery Disease | 7 | 2023 | 750 | 0.700 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 429 | 0.600 |
Why?
|
| Stroke | 3 | 2022 | 958 | 0.560 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 166 | 0.550 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.540 |
Why?
|
| American Heart Association | 1 | 2018 | 295 | 0.510 |
Why?
|
| Treatment Outcome | 20 | 2025 | 12169 | 0.500 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2022 | 716 | 0.490 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2022 | 429 | 0.490 |
Why?
|
| Atherosclerosis | 4 | 2023 | 835 | 0.480 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 357 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 373 | 0.480 |
Why?
|
| Electrocardiography | 3 | 2024 | 958 | 0.430 |
Why?
|
| Humans | 45 | 2025 | 123258 | 0.400 |
Why?
|
| Angina Pectoris | 2 | 2024 | 57 | 0.400 |
Why?
|
| Postoperative Complications | 5 | 2019 | 3020 | 0.350 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2022 | 156 | 0.340 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 716 | 0.320 |
Why?
|
| Aged | 12 | 2023 | 19194 | 0.280 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 1877 | 0.280 |
Why?
|
| Middle Aged | 12 | 2024 | 26087 | 0.250 |
Why?
|
| Diagnosis, Differential | 2 | 2024 | 1878 | 0.220 |
Why?
|
| Atrioventricular Block | 1 | 2024 | 39 | 0.220 |
Why?
|
| Risk Factors | 9 | 2025 | 10035 | 0.200 |
Why?
|
| Shock, Cardiogenic | 2 | 2022 | 190 | 0.200 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2021 | 257 | 0.200 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 196 | 0.200 |
Why?
|
| Cocaine-Related Disorders | 1 | 2024 | 202 | 0.190 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2022 | 127 | 0.190 |
Why?
|
| Comorbidity | 3 | 2022 | 1497 | 0.190 |
Why?
|
| Hypothermia | 1 | 2021 | 55 | 0.190 |
Why?
|
| Endocarditis | 1 | 2022 | 101 | 0.190 |
Why?
|
| Inpatients | 2 | 2022 | 494 | 0.180 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2021 | 45 | 0.180 |
Why?
|
| Catheterization, Peripheral | 1 | 2022 | 126 | 0.180 |
Why?
|
| Atherectomy, Coronary | 1 | 2020 | 9 | 0.170 |
Why?
|
| Hypothermia, Induced | 1 | 2021 | 161 | 0.170 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 88 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 152 | 0.170 |
Why?
|
| Preoperative Care | 2 | 2012 | 348 | 0.170 |
Why?
|
| Heart Atria | 1 | 2022 | 313 | 0.170 |
Why?
|
| Aspirin | 1 | 2021 | 220 | 0.160 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 169 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 392 | 0.160 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 275 | 0.160 |
Why?
|
| Predictive Value of Tests | 1 | 2024 | 2114 | 0.150 |
Why?
|
| Smoking | 1 | 2024 | 1031 | 0.150 |
Why?
|
| Male | 13 | 2024 | 60337 | 0.150 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 311 | 0.150 |
Why?
|
| Stents | 1 | 2024 | 876 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 360 | 0.140 |
Why?
|
| Drug-Eluting Stents | 1 | 2017 | 55 | 0.140 |
Why?
|
| Age Factors | 2 | 2020 | 2811 | 0.130 |
Why?
|
| Cocaine | 1 | 2018 | 206 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2018 | 233 | 0.130 |
Why?
|
| Pandemics | 2 | 2021 | 1099 | 0.130 |
Why?
|
| United States | 7 | 2023 | 10652 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2854 | 0.130 |
Why?
|
| Mitral Valve | 3 | 2022 | 245 | 0.130 |
Why?
|
| Psychiatric Rehabilitation | 1 | 2015 | 5 | 0.130 |
Why?
|
| Alcohol Abstinence | 1 | 2015 | 14 | 0.130 |
Why?
|
| Risk Assessment | 2 | 2025 | 3336 | 0.120 |
Why?
|
| Female | 12 | 2023 | 65619 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1237 | 0.110 |
Why?
|
| Aging | 1 | 2020 | 1185 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 1080 | 0.110 |
Why?
|
| Alcoholism | 1 | 2015 | 230 | 0.100 |
Why?
|
| Behavior Therapy | 1 | 2015 | 255 | 0.100 |
Why?
|
| Myocardial Revascularization | 2 | 2024 | 96 | 0.100 |
Why?
|
| Diuretics | 1 | 2013 | 159 | 0.100 |
Why?
|
| Colchicine | 1 | 2012 | 43 | 0.100 |
Why?
|
| Pericarditis | 1 | 2012 | 42 | 0.100 |
Why?
|
| Veterans | 1 | 2023 | 1737 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2015 | 365 | 0.090 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 210 | 0.090 |
Why?
|
| Cause of Death | 1 | 2013 | 463 | 0.090 |
Why?
|
| Heart Failure | 1 | 2023 | 2131 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2012 | 264 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2022 | 1013 | 0.080 |
Why?
|
| Pneumonia | 1 | 2012 | 325 | 0.080 |
Why?
|
| Prognosis | 1 | 2018 | 4510 | 0.080 |
Why?
|
| Registries | 1 | 2015 | 1398 | 0.080 |
Why?
|
| Sepsis | 1 | 2012 | 476 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2012 | 4701 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2013 | 16068 | 0.050 |
Why?
|
| Radial Artery | 1 | 2022 | 26 | 0.050 |
Why?
|
| Incidence | 2 | 2025 | 3053 | 0.050 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2022 | 52 | 0.050 |
Why?
|
| Mediastinum | 1 | 2022 | 41 | 0.050 |
Why?
|
| Adult | 4 | 2023 | 29100 | 0.050 |
Why?
|
| Hematoma | 1 | 2022 | 92 | 0.050 |
Why?
|
| Coma | 1 | 2021 | 54 | 0.050 |
Why?
|
| Survival Rate | 2 | 2019 | 2002 | 0.050 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2021 | 22 | 0.050 |
Why?
|
| Mortality | 1 | 2022 | 228 | 0.040 |
Why?
|
| Atherectomy | 1 | 2020 | 12 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2020 | 84 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2023 | 221 | 0.040 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 5056 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 198 | 0.040 |
Why?
|
| Vascular Calcification | 1 | 2020 | 54 | 0.040 |
Why?
|
| Cholesterol | 1 | 2022 | 528 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 344 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2021 | 671 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 458 | 0.040 |
Why?
|
| Morbidity | 1 | 2019 | 241 | 0.040 |
Why?
|
| Bisoprolol | 1 | 2018 | 9 | 0.040 |
Why?
|
| Atenolol | 1 | 2018 | 43 | 0.040 |
Why?
|
| Propanolamines | 1 | 2018 | 31 | 0.040 |
Why?
|
| Metoprolol | 1 | 2018 | 22 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2021 | 367 | 0.040 |
Why?
|
| Propranolol | 1 | 2018 | 128 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 1123 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 1142 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 630 | 0.040 |
Why?
|
| Reoperation | 1 | 2020 | 819 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 595 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 605 | 0.030 |
Why?
|
| Global Health | 1 | 2019 | 546 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3383 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 1739 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2015 | 6030 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 6392 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 967 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 333 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 1116 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 1265 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 1245 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6222 | 0.020 |
Why?
|
| Texas | 1 | 2012 | 3558 | 0.010 |
Why?
|